Loading...
•
Jun 30, 2021
Pediatrix Q2 2021 Earnings Report
Reported earnings from continuing operations.
Key Takeaways
Mednax reported strong second quarter results with net revenue of $473 million and income from continuing operations of $31 million. Adjusted EPS from continuing operations was $0.41.
Net revenue was $473 million.
Income from continuing operations was $31 million.
Adjusted EBITDA was $66 million.
Adjusted EPS from continuing operations was $0.41.
Forward Guidance
Mednax believes strong patient volume trends, focus on women’s and children’s care, operating efficiency and growth in pediatric subspecialty services put them on a positive forward path.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...